EXHIBIT 99.1 NEWS RELEASEManufacturing, Commercialization and Development Agreement • March 2nd, 2005 • Icu Medical Inc/De • Surgical & medical instruments & apparatus
AMENDMENT NO. 1Manufacturing, Commercialization and Development Agreement • August 9th, 2007 • Isis Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) amends the MANUFACTURING, COMMERCIALIZATION AND DEVELOPMENT AGREEMENT (the “Agreement”) entered into as of July 31, 2006 between ISIS PHARMACEUTICALS, INC., a Delaware corporation, through its IBIS BIOSCIENCES division (“Ibis”), and BRUKER DALTONICS INC., a Delaware corporation (“Bruker”) and is effective on the date both parties have signed below.
MANUFACTURING, COMMERCIALIZATION AND DEVELOPMENT AGREEMENTManufacturing, Commercialization and Development Agreement • November 7th, 2006 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURING, COMMERCIALIZATION AND DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of July 31, 2006 (the “Effective Date”) between ISIS PHARMACEUTICALS, INC., a Delaware corporation, through its IBIS BIOSCIENCES division (“Ibis”), and BRUKER DALTONICS INC., a Delaware corporation (“Bruker”).
ICU MEDICAL, INC. ICU MEDICAL (UTAH), INC. 951 CALLE AMANECER SAN CLEMENTE, CALIFORNIA 92673 July 8, 2005Manufacturing Commercialization and Development Agreement • August 5th, 2005 • Icu Medical Inc/De • Surgical & medical instruments & apparatus
Re: Manufacturing Commercialization and Development Agreement dated February 25, 2005 between ICU Medical, Inc. and Hospira, Inc.
news releaseManufacturing, Commercialization and Development Agreement • February 28th, 2005 • Hospira Inc • Pharmaceutical preparations
For Immediate Release Hospira Media Tareta Adams (224) 212-2535 Financial Community Lynn McHugh (224) 212-2363 ICU Medical Media and Financial Community Francis J. O’Brien (949) 366-2183 John F. Mills Integrated Corporate Relations (310) 395-2215
